ATE237326T1 - Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung - Google Patents

Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung

Info

Publication number
ATE237326T1
ATE237326T1 AT97935773T AT97935773T ATE237326T1 AT E237326 T1 ATE237326 T1 AT E237326T1 AT 97935773 T AT97935773 T AT 97935773T AT 97935773 T AT97935773 T AT 97935773T AT E237326 T1 ATE237326 T1 AT E237326T1
Authority
AT
Austria
Prior art keywords
methyl
methoxyphenyl
prevention
acetamido
acetate
Prior art date
Application number
AT97935773T
Other languages
English (en)
Inventor
Sergio Anzalone
Original Assignee
Medosan Ricerca Srl
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Ricerca Srl, Sigma Tau Ind Farmaceuti filed Critical Medosan Ricerca Srl
Application granted granted Critical
Publication of ATE237326T1 publication Critical patent/ATE237326T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97935773T 1997-08-08 1997-08-08 Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung ATE237326T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT1997/000209 WO1999007363A1 (en) 1997-08-08 1997-08-08 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment

Publications (1)

Publication Number Publication Date
ATE237326T1 true ATE237326T1 (de) 2003-05-15

Family

ID=11332729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97935773T ATE237326T1 (de) 1997-08-08 1997-08-08 Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung

Country Status (6)

Country Link
EP (1) EP1024807B1 (de)
JP (1) JP2001513497A (de)
AT (1) ATE237326T1 (de)
DE (1) DE69721077T2 (de)
DK (1) DK1024807T3 (de)
WO (1) WO1999007363A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1297140B1 (it) * 1997-12-24 1999-08-03 Sigma Tau Ind Farmaceuti Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e
IT1302898B1 (it) * 1998-12-03 2000-10-10 Medosan Ricerca Srl Uso di amtolmetine guacil per la produzione di farmaci ad effettoantiinfiammatorio nelle infiammazioni intestinali.
JP2006519225A (ja) * 2003-02-27 2006-08-24 社団法人芝蘭会 依存症治療用医薬組成物
CN100390144C (zh) * 2006-03-29 2008-05-28 安徽省庆云医药化工有限公司 1-甲基-5-对甲苯酰吡咯-2-乙酰氨基乙酸愈创木酚酯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1162856A (en) * 1981-07-20 1984-02-28 Dushan M. Dvornik Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5- methoxy-2-methyl-1h-indole-3-acetic acid
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.

Also Published As

Publication number Publication date
DE69721077T2 (de) 2004-02-05
DK1024807T3 (da) 2003-08-04
WO1999007363A1 (en) 1999-02-18
JP2001513497A (ja) 2001-09-04
DE69721077D1 (de) 2003-05-22
EP1024807A1 (de) 2000-08-09
EP1024807B1 (de) 2003-04-16

Similar Documents

Publication Publication Date Title
BG105880A (en) Compounds useful as anti-inflammatory agents
DE69004081T2 (de) Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
ATE288265T1 (de) Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen
ATE218336T1 (de) Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom
DE69526183T2 (de) 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen
WO2003039454A3 (en) Beta-secretase inhibitors and methods of use
CA2465534A1 (en) Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
DE69713300D1 (de) Benzopyran derivate mit leukotrien-antagonistischer wirkung
BG104726A (en) Novel derivatives of the dihydroxyhexanoic acid
ATE270100T1 (de) Ibuprofenthioester als hemmer der nf-kappa b abhängigen bildung von mediatoren von entzündung und schmerz
WO1999048489A3 (en) Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
DE69832695D1 (de) Verwendung von r-enantiomeren nichtsteroidaler entzündungshemmer zur vorbeugung der alzheimerschen krankheit
DE69718469T2 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
ATE237326T1 (de) Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrro -2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung
ATE415965T1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
ATE297722T1 (de) Verwendung von gaba analoga wie gabapentin zur herstellung eines medikaments für die behandlung von entzündungserkrankungen
ATE345121T1 (de) Verwendung von konjugierter linolsäure zur behandlung der erkältung
NO20005360L (no) Sammensetning for fremstilling av brennstoffbriketter
FI951759A0 (fi) Menetelmä 2,2-difluoriketeenisilyyli-O,S-asetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihapon O,S-estereiden valmistamiseksi
DE59609977D1 (de) Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern
TR199701605A2 (xx) S�lfonamid-substit�e edilmi� bile�ikler
WO1996020690A3 (en) 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
MX9704740A (es) Monomeros de 3,3-(disustituido)ciclohexan-1-ol y compuestos relacionados.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1024807

Country of ref document: EP